 |
cl.jpg) |
|
|
|
Influenza A detection by direct fluorescent antibody (DFA). Green: Influenza A. Red: Uninfected cells stained with Evans Blue dye |
|
|
|
|
Clinical Virology
The Stanford Clinical Virology Laboratory provides a full range of diagnostic services for the detection and monitoring of viral illnesses in both the adult and pediatric patient populations at Stanford University Hospital and the Lucile Packard Children’s Hospital.
Our goals are to:
- Provide the highest quality patient care
- Serve as vital consultants to our physicians for test selection and interpretation
- Bring the latest technology for viral disease diagnosis to the clinical laboratory
- Advance clinical, translational, and basic research
Dr. Benjamin Pinsky is available for consultation on diagnostic test selection and the interpretation of results at (650) 721-1896 [or page him at (650) 723-8222; pager 13118)].
For questions about clinical infectious diseases please contact the appropriate Stanford Infectious Diseases Service Fellow:
- Adult ID Fellow Pager: (650) 723-8222; pager 13536
- Pediatric ID Fellow Pager: (650) 723-8222; pager 13585
The Stanford Clinical Virology Laboratory provides testing for the primary identification of a wide variety of viral infections (such as respiratory viruses, herpes viruses, enteroviruses, and many others), the monitoring of viral load in chronic disease (HIV, HCV, and HBV), and the quantitative assessment of viral infection/reactivation in transplant and other immunocompromised patients (CMV, EBV, and BK). The laboratory identifies high risk HPV part of cervical cancer screening triage and also works closely with the microbiology laboratory for the identification of the genital tract pathogens Neisseria gonorrhoeae and Chlamydia trachomatis. Nearly fifteen years ago, the laboratory became among the first in the world to offer HIV genotyping and antiviral resistance testing, and we continue to provide this important service to numerous patients and research clients, including the Centers for Disease Control and Prevention (CDC).
To achieve this breadth of testing, we utilize all diagnostic modalities at our disposal including viral culture and direct viral antigen detection, infectious disease serology, nucleic acid amplification techniques, and sequencing technologies. Furthermore, we are actively involved in the research and development of novel diagnostics to remain at the forefront of patient care.
New Tests (2009-10):
- Influenza A RNA detection
- Influenza A 2009 (H1N1) subtyping and oseltamivir (Tamiflu) resistance testing
- HCV genotyping
- BK virus DNA quantitation
- HIV integrase inhibitor resistance testing
Recent publications:
Preferential lower respiratory tract infection of swine-origin 2009 A (H1N1) influenza. 2010. Ellen Yeh, Robert F. Luo, Laura Le Dyner, David K. Hong, Niaz Banaei, Ellen Jo Baron, and Benjamin A. Pinsky. Clinical Infectious Diseases. 2010 Feb 1;50(3):391-4.
Long-term shedding of influenza A virus in stool of immunocompromised child.
Benjamin A. Pinsky, Samantha Mix, Judy Rowe, Sheryl Ikemoto, and Ellen Jo Baron. Emerging Infectious Diseases. 2010 Jul;16(7):1165-7.
